- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arcutis Biotherapeutics Inc (ARQT)Arcutis Biotherapeutics Inc stock price live, this page displays NASDAQ ARQT stock exchange data. View the ARQT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arcutis Biotherapeutics Inc real time stock price chart below.
What Is the Arcutis Biotherapeutics Inc Stock Price Today?
The Arcutis Biotherapeutics Inc stock price today is 12.40.
What Is the Stock Symbol for Arcutis Biotherapeutics Inc?
The stock symbol for Arcutis Biotherapeutics Inc is "ARQT."
What Stock Exchange Does Arcutis Biotherapeutics Inc Trade On?
Arcutis Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Arcutis Biotherapeutics Inc a Good Stock to Buy?
Determining whether Arcutis Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARQT quote. (ISIN: US03969K1088)
What Is the Arcutis Biotherapeutics Inc Stock Price Today?
The Arcutis Biotherapeutics Inc stock price today is 12.40.
What Is the Stock Symbol for Arcutis Biotherapeutics Inc?
The stock symbol for Arcutis Biotherapeutics Inc is "ARQT."
What Stock Exchange Does Arcutis Biotherapeutics Inc Trade On?
Arcutis Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Arcutis Biotherapeutics Inc a Good Stock to Buy?
Determining whether Arcutis Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARQT quote. (ISIN: US03969K1088)
NASDAQ
Currency in USD
12.40
+0.09(+0.73%)
Closed
After Hours
12.56+0.16(+1.29%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.15
12.98
52 wk Range
1.89
13.50
ARQT Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.1512.98
52 wk Range
1.8913.50
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockARQT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
19.00
Upside
+53.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Arcutis announces key executive promotions
- Investing.com
- Arcutis Biotherapeutics exec buys $7,766 in stock
- Investing.com
- Arcutis Biotherapeutics exec buys $7,766 in stock
- Investing.com
Arcutis Company Profile
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Compare ARQT to Peers and Sector
Metrics to compare | ARQT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARQTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.4x | −1.9x | −0.6x | |
PEG Ratio | −0.13 | 0.04 | 0.00 | |
Price/Book | 9.3x | 1.9x | 2.6x | |
Price / LTM Sales | 10.5x | 19.5x | 3.2x | |
Upside (Analyst Target) | 47.9% | 374.7% | 44.6% | |
Fair Value Upside | Unlock | 10.0% | 7.3% | Unlock |
Analysts' Recommendations
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 19.00
(+53.23% Upside)
FAQ
What Is the Arcutis (ARQT) Stock Price Today?
The Arcutis stock price today is 12.40.
What Stock Exchange Does Arcutis Trade On?
Arcutis is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Arcutis?
The stock symbol for Arcutis is "ARQT."
What Is the Arcutis Market Cap?
As of today, Arcutis market cap is 1.45B.
What is Arcutis Earnings Per Share?
The Arcutis EPS is -1.73.
What Is the Next Arcutis Earnings Date?
Arcutis will release its next earnings report on 03 Mar 2025.
From a Technical Analysis Perspective, Is ARQT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.